FDA Drug Application (205831) for APTENSIO XR by RHODES PHARMS

Back to FDA Applications sponsored by RHODES PHARMS

Application Number205831
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage10MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAPTENSIO XR
Active IngredientMETHYLPHENIDATE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient METHYLPHENIDATE HYDROCHLORIDE12


Back to FDA Applications sponsored by RHODES PHARMS